IPHA
Innate Pharma
IPHA
IPHA
16 hedge funds and large institutions have $6.52M invested in Innate Pharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.81M | |
| 2 | +$839K | |
| 3 | +$431K | |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$429K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$333K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$771K | |
| 3 | -$450K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$124K |
| 5 |
LPL Financial
San Diego,
California
|
-$114K |